These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34244019)

  • 21. Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.
    Meola G; Cardani R
    Neurol Sci; 2017 Apr; 38(4):535-546. PubMed ID: 28078562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and Validation of a New Molecular Diagnostic Assay for Detection of Myotonic Dystrophy Type 2.
    Valaperta R; Lombardi F; Cardani R; Fossati B; Brigonzi E; Merli I; Sansone V; Merletti G; Spina E; Meola G; Costa E
    Genet Test Mol Biomarkers; 2015 Dec; 19(12):703-9. PubMed ID: 26505324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myotonic dystrophy type 2 and related myotonic disorders.
    Meola G; Moxley RT
    J Neurol; 2004 Oct; 251(10):1173-82. PubMed ID: 15503094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myotonic dystrophy type 2.
    Finsterer J
    Eur J Neurol; 2002 Sep; 9(5):441-7. PubMed ID: 12220374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cultured myoblasts from patients affected by myotonic dystrophy type 2 exhibit senescence-related features: ultrastructural evidence.
    Malatesta M; Giagnacovo M; Renna LV; Cardani R; Meola G; Pellicciari C
    Eur J Histochem; 2011; 55(3):e26. PubMed ID: 22073373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Premutation allele pool in myotonic dystrophy type 2.
    Bachinski LL; Czernuszewicz T; Ramagli LS; Suominen T; Shriver MD; Udd B; Siciliano MJ; Krahe R
    Neurology; 2009 Feb; 72(6):490-7. PubMed ID: 19020295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of repetitive regions in myotonic dystrophy type 1 and 2.
    Carson NL
    Curr Protoc Hum Genet; 2009 Apr; Chapter 9():Unit 9.6. PubMed ID: 19360700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract.
    Liquori CL; Ikeda Y; Weatherspoon M; Ricker K; Schoser BG; Dalton JC; Day JW; Ranum LP
    Am J Hum Genet; 2003 Oct; 73(4):849-62. PubMed ID: 14505273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deregulated microRNAs in myotonic dystrophy type 2.
    Greco S; Perfetti A; Fasanaro P; Cardani R; Capogrossi MC; Meola G; Martelli F
    PLoS One; 2012; 7(6):e39732. PubMed ID: 22768114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 14-Year Italian Experience in DM2 Genetic Testing: Frequency and Distribution of Normal and Premutated
    Botta A; Visconti VV; Fontana L; Bisceglia P; Bengala M; Massa R; Bagni I; Cardani R; Sangiuolo F; Meola G; Antonini G; Petrucci A; Pegoraro E; D'Apice MR; Novelli G
    Front Genet; 2021; 12():668094. PubMed ID: 34234810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-level profiling unravels mitochondrial dysfunction in myotonic dystrophy type 2.
    Kleefeld F; Horvath R; Pinal-Fernandez I; Mammen AL; Casal-Dominguez M; Hathazi D; Melchert S; Hahn K; Sickmann A; Muselmann-Genschow C; Hentschel A; Preuße C; Roos A; Schoser B; Stenzel W
    Acta Neuropathol; 2024 Jan; 147(1):19. PubMed ID: 38240888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2.
    Weber YG; Roebling R; Kassubek J; Hoffmann S; Rosenbohm A; Wolf M; Steinbach P; Jurkat-Rott K; Walter H; Reske SN; Lehmann-Horn F; Mottaghy FM; Lerche H
    Neurology; 2010 Apr; 74(14):1108-17. PubMed ID: 20220122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
    Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
    Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uninterrupted CCTG tracts in the myotonic dystrophy type 2 associated locus.
    Radvanszky J; Surovy M; Polak E; Kadasi L
    Neuromuscul Disord; 2013 Jul; 23(7):591-8. PubMed ID: 23561036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive assessment in patients with myotonic dystrophy type 2.
    Peric S; Gunjic I; Delic N; Stojiljkovic Tamas O; Salak-Djokic B; Pesovic J; Petrovic Djordjevic I; Ivanovic V; Savic-Pavicevic D; Meola G; Rakocevic-Stojanovic V
    Neuromuscul Disord; 2022 Sep; 32(9):743-748. PubMed ID: 35879188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2).
    Sallinen R; Vihola A; Bachinski LL; Huoponen K; Haapasalo H; Hackman P; Zhang S; Sirito M; Kalimo H; Meola G; Horelli-Kuitunen N; Wessman M; Krahe R; Udd B
    Neuromuscul Disord; 2004 Apr; 14(4):274-83. PubMed ID: 15019706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The current clinical perception of myotonic dystrophy type 2.
    Kleefeld F; Schoser B
    Curr Opin Neurol; 2023 Oct; 36(5):474-478. PubMed ID: 37639480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal splicing of NEDD4 in myotonic dystrophy type 2: possible link to statin adverse reactions.
    Screen M; Jonson PH; Raheem O; Palmio J; Laaksonen R; Lehtimäki T; Sirito M; Krahe R; Hackman P; Udd B
    Am J Pathol; 2014 Aug; 184(8):2322-32. PubMed ID: 24907641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of brain atrophy in patients with myotonic dystrophy and proximal myotonic myopathy: a controlled 3-dimensional magnetic resonance imaging study.
    Kassubek J; Juengling FD; Hoffmann S; Rosenbohm A; Kurt A; Jurkat-Rott K; Steinbach P; Wolf M; Ludolph AC; Lehmann-Horn F; Lerche H; Weber YG
    Neurosci Lett; 2003 Sep; 348(2):73-6. PubMed ID: 12902021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myotonic dystrophy type 2: the 2020 update.
    Meola G
    Acta Myol; 2020 Dec; 39(4):222-234. PubMed ID: 33458578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.